NYSE:ADM
NYSE:ADMFood

Archer-Daniels-Midland (ADM): Has the Recent Rebound Left the Stock Slightly Overvalued?

Archer-Daniels-Midland (ADM) has quietly outperformed much of the market this year, with the stock up about 16% year to date and roughly 20% over the past year despite modest revenue growth. See our latest analysis for Archer-Daniels-Midland. That move reflects investors slowly warming back up to ADM after a tough stretch, with a near 20% one year total shareholder return contrasting sharply with its negative three year total shareholder return. If ADM’s steady rebound has you thinking about...
NasdaqGS:LAUR
NasdaqGS:LAURConsumer Services

Laureate Education (LAUR) Is Up 5.3% After Expanding Buybacks And Raising Guidance Has The Bull Case Changed?

In recent months, Laureate Education reported revenue growth, raised its full-year guidance, expanded its share repurchase authorization to US$250 million, and attracted new institutional investment from Montreal-based Formula Growth, which acquired 111,000 shares worth about US$3.50 million. These developments, supported by solid enrollment trends, especially in Peru, and a net cash position, have reinforced confidence in Laureate’s business strength and capital allocation approach. With...
NYSE:HLI
NYSE:HLICapital Markets

Revisiting Houlihan Lokey’s Valuation: Is HLI’s Long-Term Outperformance Already Priced In?

Houlihan Lokey (HLI) has quietly outperformed many Wall Street peers over the past few years, so with the stock hovering near 176 dollars, it is a good moment to revisit what investors are actually paying for. See our latest analysis for Houlihan Lokey. Over the past year, Houlihan Lokey’s share price return has been modest even as the 5 year total shareholder return of 188.52 percent signals a powerful longer term compounding story, suggesting recent momentum is cooling rather than breaking...
NYSE:CHD
NYSE:CHDHousehold Products

Reassessing Church & Dwight (CHD): Has the Recent Slide Opened a Better Valuation Entry Point?

Church & Dwight (CHD) has quietly slipped about 18% this year, even as its earnings and revenue keep inching higher. That disconnect is what has value focused investors taking a closer look right now. See our latest analysis for Church & Dwight. The recent slide has come despite steady mid single digit revenue and high single digit net income growth, suggesting investors are reassessing how much they are willing to pay for this defensive staples name rather than reacting to any sharp...
NasdaqGS:TXN
NasdaqGS:TXNSemiconductor

The Bull Case For Texas Instruments (TXN) Could Change Following New Sherman Fab Ramp-Up Plan – Learn Why

Texas Instruments has begun production at its new 300mm semiconductor wafer fabrication plant in Sherman, Texas, a key step in its multi-fab US manufacturing build-out to supply industrial, automotive, medical and data center customers. This expansion, part of a broader plan to invest up to US$60.00 billion in connected fabs, is sparking debate over how much near-term margin pressure is acceptable to secure long-term supply control and customer reliability. Now we’ll explore how ramping the...
NYSE:BBY
NYSE:BBYSpecialty Retail

Best Buy (BBY): Reassessing Valuation After Recent Share Price Pullback and Profit Growth

Best Buy (BBY) has drifted lower over the past month, even as its latest annual numbers showed modest revenue growth and a near 19% jump in net income, raising some interesting questions about valuation. See our latest analysis for Best Buy. At around $71.83, the 1 year to date share price return of negative 16.64 percent and 1 year total shareholder return of negative 11.52 percent suggest momentum has cooled lately. However, the 3 year total shareholder return of 1.97 percent hints that...
NYSE:TWLO
NYSE:TWLOIT

Is Twilio (TWLO) Turning Sports Partnerships Into a Durable AI Engagement Advantage?

Earlier this month, the LA Kings announced a multi‑year partnership making Twilio their official away helmet sponsor from the 2025‑26 NHL season, featuring prominent logo placement and co‑created content that showcases Twilio’s technology during regular season and playoff games. Beyond brand exposure, the deal uses Twilio’s engagement platform to power more personalized fan communications and interactive experiences, highlighting real‑world adoption of its customer engagement tools by a...
NYSE:AME
NYSE:AMEElectrical

How AMETEK’s New SmartTank ST705 Radar Sensor Could Shape AME Investors’ Connected-Industry Thesis

Earlier this week, AMETEK’s SkyBitz business launched the SmartTank ST705 Radar Monitor, a C1D1-certified, non-contact liquid-level sensor that delivers real-time monitoring for fuels, chemicals, lubricants, waste oil, and other industrial fluids, integrating with the SmartTank Portal and Tank Installer Mobile App for faster deployment and data access. This new radar-based, non-invasive sensor, with support for varied tank materials and shapes and battery life of up to 10 years, underscores...
NYSE:KMPR
NYSE:KMPRInsurance

Reassessing Kemper (KMPR) Valuation After William Blair’s Downgrade and Growing Analyst Caution

William Blair’s downgrade of Kemper (KMPR) from Market Perform to Underperform has sharpened the spotlight on the insurer, as a string of cautious calls nudges investors to reassess expectations. See our latest analysis for Kemper. That more cautious stance comes after a choppy stretch, with Kemper’s 1 month share price return of 4.62 percent failing to offset a 90 day share price decline of 21.30 percent and a 1 year total shareholder return of negative 35.77 percent. This signals that...
NYSE:DLB
NYSE:DLBSoftware

Should Dolby’s New LG Sound Suite And First U.S. Vision+Atmos Cinema Rollout Require Action From Dolby Laboratories (DLB) Investors?

In December 2025, Dolby Laboratories and LG Electronics unveiled the LG Sound Suite, a modular home audio system built around the H7 soundbar powered by Dolby Atmos FlexConnect, while The Movie Experience SLO became the first U.S. exhibitor to adopt Dolby’s combined Dolby Vision+Atmos cinema solution. Together, these launches show how Dolby is extending its Atmos and Vision ecosystem across both home and theatrical experiences, reinforcing its role at the center of premium entertainment...
NasdaqGM:VERA
NasdaqGM:VERABiotechs

Vera’s New Capital Raise and Legal Transition Might Change The Case For Investing In Vera Therapeutics (VERA)

In December 2025, Vera Therapeutics completed a US$260.87 million follow-on offering of 6,138,108 Class A common shares at US$42.50, while also announcing that Chief Legal Officer Jason Carter will step down effective December 24, 2025. The sizeable capital raise, coming shortly before a change in the company’s top legal leadership, highlights both Vera’s funding ambitions and governance transition. With this large follow-on offering as a backdrop, we’ll now examine how these developments...
NYSE:CRS
NYSE:CRSAerospace & Defense

Carpenter Technology (CRS) Valuation After NYSE Composite Inclusion and Strong Recent Share Price Performance

Carpenter Technology (CRS) just earned a spot in the NYSE Composite index, a move that puts this specialty metals manufacturer on more investors’ radar as index-tracking funds realign their portfolios. See our latest analysis for Carpenter Technology. The timing could hardly be better, with a 90 day share price return of 34.77% and a powerful 1 year total shareholder return of 93.22% indicating clear positive momentum behind the $327.15 stock. If Carpenter’s surge has you rethinking your...
NasdaqGS:TSCO
NasdaqGS:TSCOSpecialty Retail

Tractor Supply (TSCO): Reviewing Valuation After Two Years of Weak Same-Store Sales and Slower Revenue Growth

Recent commentary around Tractor Supply (TSCO) has zeroed in on two weak spots: slower revenue growth and soft same store sales, which together suggest its rural retail formula is feeling the heat from tougher competition and thinner margins. See our latest analysis for Tractor Supply. The recent 1 month share price return of minus 2.9 percent and 3 month share price return of minus 11.6 percent suggest momentum is fading at the current 51.40 dollars share price, even though the 5 year total...
NYSE:GWRE
NYSE:GWRESoftware

Guidewire’s Heritage Cloud Win and New Olos AI Suite Could Be A Game Changer For GWRE

Earlier this month, Heritage Insurance Company and Guidewire reported that Heritage has gone live with Guidewire PolicyCenter and BillingCenter on Guidewire Cloud Platform across homeowners and dwelling fire products in 13 states, completing its migration to the full InsuranceSuite after deploying ClaimCenter in 2023. Guidewire also introduced its Olos release, which adds unified pricing management, new AI-powered underwriting and claims tools, and an agentic AI framework, underscoring its...
NYSE:STT
NYSE:STTCapital Markets

Is State Street’s New ETF Wins And OCC Role Quietly Recasting Its Core Edge In Markets (STT)?

State Street Corporation recently announced several developments, including a US$0.84 quarterly dividend payable on January 12, 2026, new ETF servicing mandates for Dimensional Fund Advisors in Europe, and its role as the first bank clearing member at the Options Clearing Corporation. Together with expectations for upcoming fourth-quarter 2025 results, these client wins and clearing capabilities highlight how State Street is deepening its role at the center of global institutional investing...
NYSE:LBRT
NYSE:LBRTEnergy Services

Is Liberty Energy (LBRT) Quietly Recasting Its Cyclical Fracking Story Into a Power-Utility Narrative?

In recent months, Liberty Energy Inc. has outlined a shift from its traditional North American hydraulic fracturing roots toward behind-the-meter power solutions, targeting large, always-on customers such as data centers and aiming to secure more than 1 GW of contracted capacity by 2027. This evolution suggests Liberty Energy is seeking to reposition itself as an integrated energy and power provider, using its technology and project capabilities to tap long-duration, infrastructure-like...
NYSE:THR
NYSE:THRElectrical

What Thermon Group Holdings (THR)'s Big Earnings Beat and Upgrades Mean For Shareholders

In the past few days, Thermon Group reported revenue, EPS, and EBITDA results that were well ahead of analyst expectations, delivering the largest earnings beat among its electrical systems peers and driving strong positive revisions to earnings estimates for the current and next fiscal years. This combination of outperformance and upward estimate revisions has strengthened Thermon’s momentum profile, highlighting how earnings quality and consistency are increasingly central to the company’s...
NYSE:BMI
NYSE:BMIElectronic

Badger Meter (BMI) Valuation Check as CFO Transition Reshapes Financial Leadership and Strategy

Badger Meter (BMI) just reshuffled its leadership team, with long time finance insider Daniel Weltzien stepping into the CFO role and former CFO Robert Wrocklage shifting into a key operating position. See our latest analysis for Badger Meter. The leadership reshuffle lands after a tough stretch for shareholders, with the stock at $181.64 and a negative year to date share price return, even though the three year total shareholder return above 60 percent still points to a strong longer term...
NYSE:VLO
NYSE:VLOOil and Gas

Is It Too Late To Buy Valero After Its 250% Five Year Surge?

If you are wondering whether Valero Energy at around $162 a share is still good value after its huge run, or if you would be buying in too late, this article will walk through that question step by step. Even after a recent pullback of about 3.3% over the last week and 6.2% over the last month, the stock is still up 32.1% year to date and 41.5% over the last year, with a 250.6% gain over five years. Those moves have been supported by a strong refining backdrop, including robust crack spreads...
NasdaqGS:MDGL
NasdaqGS:MDGLBiotechs

Assessing Madrigal Pharmaceuticals (MDGL) Valuation After Bullish Rezdiffra Data, FDA Designations and Analyst Upgrades

Madrigal Pharmaceuticals (MDGL) has been climbing after upbeat FDA designations for Rezdiffra and encouraging Phase 3 MAESTRO-NAFLD-1 data, showing improved liver biomarkers in MASH cirrhosis, which is sharpening investor focus on its long term runway. See our latest analysis for Madrigal Pharmaceuticals. The latest FDA designations, upbeat MAESTRO-NAFLD-1 data and a stream of bullish research coverage have fed directly into a powerful rerating, with an 8.56% 1 day share price return helping...
NasdaqGS:NCNO
NasdaqGS:NCNOSoftware

Assessing nCino (NCNO) Valuation After Insight’s Exit and a New $100m Stock Buyback Program

nCino (NCNO) just landed in the spotlight after a big shareholder, Insight Holdings Group, fully exited its stake while the company rolled out a fresh 100 million dollar stock buyback program. See our latest analysis for nCino. At a share price of $25.68, nCino has seen a modest 1 month share price return of 5.29%, but its 1 year total shareholder return of minus 27.09% shows momentum has been fading despite solid underlying revenue growth. If this mix of insider exits and buybacks has you...
NYSE:PII
NYSE:PIILeisure

Does Polaris’ (PII) Racing Dominance and Premium Slingshot Line Reveal a Deeper Brand Strategy Shift?

In December 2025, Polaris announced its 2026 Slingshot lineup, highlighted by a limited-edition Grand Touring model with premium iridescent paint, new Honeycomb wheels, and the subscription-based RIDE COMMAND+ connectivity suite. These launches, alongside Polaris RZR Factory Racing’s sweep of every major 2025 off-road event including Dakar and King of the Hammers, reinforce the brand’s performance credentials and premium positioning. We’ll now examine how Polaris RZR Factory Racing’s...
NasdaqGS:HWKN
NasdaqGS:HWKNChemicals

Assessing Hawkins (HWKN) Valuation After Strong Long-Term Returns and Recent Share Price Pullback

Hawkins (HWKN) has quietly delivered a mix of modest recent moves and strong longer term gains, which naturally raises the question of whether today’s price still reflects its fundamentals. See our latest analysis for Hawkins. With the share price up 13.51% over the past month but down 16.26% on a 90 day share price return basis, while posting a powerful 5 year total shareholder return of 482.74%, Hawkins still looks like a name where long term momentum outweighs the recent wobble. If Hawkins...
NasdaqGM:ORKA
NasdaqGM:ORKABiotechs

Will Oruka Therapeutics (ORKA) New Director Hire Redefine Its Commercial Strategy Or Simply Refine It?

Earlier this month, Oruka Therapeutics announced that director Cameron Turtle resigned from its Board and was replaced by Christopher Martin, a veteran commercial leader who will serve as a Class II director, Compensation Committee Chair, and Audit Committee member through the 2026 annual meeting. Investors may focus on Martin’s track record in preparing multiple first-time drug launches and his recent role at Verona Pharma, which was acquired by Merck for approximately US$10.00 billion...